Executive Summary
Across 50 filings dated April 13, 2026, dominant themes include major M&A activity like Somnigroup's $2.5B all-stock acquisition of Leggett & Platt (yielding $11.2B combined sales, immediate EPS accretion), biotech IPO pursuits (Alamar Biosciences +195% YoY revenue to $74.2M, Kailera's Phase 3 obesity pipeline), and a wave of Indian insolvencies/open offers (AGS Transact CIRP, Reliance Home Finance CoC meeting, multiple open offers at 26% stakes). Period-over-period trends show polarized performance: revenue growth in 6/18 reporting companies averaging +85% YoY (e.g., Alamar 195%, EACO 17.7%), but margin compression in 5/18 (Digital Ally to 10% from 23%, ALT5 to 41% from 48%) and net losses widening in microcaps (ALT5 -$344k from -$7.5k). RBI filings highlight persistent liquidity deficits (₹5.54L Cr absorption, SDF heavy usage), signaling tight Indian money markets. Critical implications: M&A catalysts for industrials, delisting risks (Sow Good Nasdaq notice), leadership transitions (Conagra CEO change, AdvanSix CFO), with forward catalysts like Phase 3 readouts (Kailera 2028), LEG merger close YE2026. Portfolio pattern: Outliers in biotech/health (positive sentiment 7/10) vs distress in small caps/fintech (negative/mixed 8/12).
Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from April 06, 2026.
Investment Signals(12)
- Alamar Biosciences↓(BULLISH)▲
Revenue surged 195% YoY to $74.2M (product +257% to $58.4M), gross profit to $41.7M, IPO pricing $16/share for $133M net proceeds, post 1:2.418 reverse split
- EACO Corp↓(BULLISH)▲
Q2 FY26 revenue +17.7% YoY to $117.8M, gross margin expanded to 30.7% (+120bps), net income +45% to $9.8k, 6-mo net +40% to $19.1k, cash up to $5.1k from $0.7k
- OriginClear↓(BULLISH)▲
FY25 revenue +55% YoY to $6.8M, gross profit +8% to $1.6M, operating loss narrowed to $3.3M from $6.2M, liabilities -49% to $26.7M, shareholders' deficit halved to -$28.4M
- Somnigroup International (LEG Acquisition)(BULLISH)▲
$2.5B all-stock deal for LEG at 0.1455x ratio, combined $11.2B sales/$1.7B EBITDA, $50M synergies, immediate EPS accretion, LEG leverage 2.4x
- Comstock Holding↓(BULLISH)▲
Acquired 6.77-acre Woodland Pointe campus with full Peraton lease (285k sq ft), advancing Institutional Venture Platform, positioned in Dulles Tech Corridor
- AdvanSix↓(BULLISH)▲
Appointed Patrick Day as SVP/CFO effective Apr 27, ex-FMC FP&A/IR leader, replacing interim, strengthens growth leadership
- Conagra Brands↓(BULLISH)▲
John Brase appointed CEO effective Jun 1 (35+ yrs exp, led $6B Smucker biz), succeeding Connolly, FY25 $12B sales pure-play food co
- Palo Alto Networks↓(BULLISH)▲
Extended Santa Clara lease 144 mos to 2040 (+2x72-mo options to 2052), 290k sq ft at escalating $13-16M annual rent, no defaults
- Angel Studios↓(BULLISH)▲
Priced 14.3M share offering at $2.10 ($30M gross), +2.1M underwriter option, funds capex/working capital, top industry audience scores
- Pershing Square Holdco↓(BULLISH)▲
S-1/A for PSUS IPO/private placement expanding AUM, $2.1B Vantage close Q2 2026, predictable $3.75M qtrly fees + perf fees
- Kailera Therapeutics↓(BULLISH)▲
S-1/A IPO for GLP-1 pipeline, Phase 3 ribupatide (23.6% weight loss 12wks), oral Phase 3 H1 2027, topline 2028
- ImageneBio↓(BULLISH)▲
$30M private placement pre-funded warrants at $5.20/share, funds late-phase atopic dermatitis/alopecia expansion
Risk Flags(10)
- Sow Good↓[HIGH RISK]▼
Nasdaq notice for < $2.5M equity (Listing Rule 5550(b)(1)) per 10-K, plan due May 22 or delist risk to Oct 4, despite $100M ATM offering
- Ameriguard Security (Contract Loss)[HIGH RISK]▼
Subsidiary lost $9M/yr VA Long Beach contract (58% 2026 rev), 7.5-yr hold, transition Apr 2026, protest planned
- Mobile Global Esports↓[HIGH RISK]▼
CFO Consultant Mark Keeley resigned Apr 9, no reasons, CEO interim principal accounting officer, OTC Pink
- ALT5 Sigma↓[HIGH RISK]▼
FY25 revenue doubled to $24.8k but gross margin -700bps to 41%, op loss to -$22.9k, net -$344k on $402k crypto loss, Adj EBITDA -$15.4k
- Digital Ally↓[HIGH RISK]▼
FY25 rev +1.7% to $13.8M but Video rev -11%, product -20%, gross margin crushed to 10% from 23%, op loss -79% rev
- AGS Transact Technologies↓[HIGH RISK]▼
11th CoC meeting Apr 10 under CIRP, no outcomes, ongoing insolvency process
- Skyline Ventures↓[HIGH RISK]▼
FIR for Rs1.78Cr fraud by ex-directors (fake work order), Rs10.45Cr impact, IBC petition Nov 2025, AGM rejected FY statements
- Reliance Home Finance↓[MEDIUM RISK]▼
9th CoC meeting Apr 15 under CIRP since Sep 2025, no details
- Zhanling International↓[MEDIUM RISK]▼
Q3 net loss +11% to $26.9k, no revenue, cash $0, dilution to 3.4M shares from 73k, related party advances $38.7k
- NCL Industries↓[LOW RISK]▼
NSE fine Rs54k for delayed Q4 2025 shareholding pattern, waiver rejected
Opportunities(10)
- Somnigroup-LEG Merger↓(OPPORTUNITY)◆
All-stock $2.5B deal, LEG owners 9% combined, $50M synergies ($10M yr1), close YE2026, no SGI vote needed, vertical integration
- Alamar Biosciences IPO(OPPORTUNITY)◆
9.4M shares $16 midpoint, $133M net (~$154M full), post-IPO 65M shares, 195% rev growth, Nasdaq ALMR
- Kailera Therapeutics IPO(OPPORTUNITY)◆
GLP-1 obesity pipeline, Phase 3 KaiNETIC trials (topline 2028), 23.6% weight loss data, oral initiator H1 2027
- Pershing Square PSUS IPO(OPPORTUNITY)◆
Flagship NYSE vehicle, expands AUM via $2.1B Vantage Q2 close, mgmt fees + perf, diversified holdings
- Comstock-Peraton Lease↓(OPPORTUNITY)◆
Full-campus 300k sq ft occupancy in Dulles Corridor, institutional co-invest, ex-Volkswagen HQ LEED Gold
- EACO Corp Growth↓(OPPORTUNITY)◆
17.7% YoY Q2 rev, 30.7% margins (+120bps), cash build to $5k, inventory up signaling demand
- OriginClear Turnaround(OPPORTUNITY)◆
55% rev growth, op loss halved, liabilities -49%, discontinued ops profitable $0.46M
- Clear Channel Consent(OPPORTUNITY)◆
Amendments to $2.9B notes effective pre-merger (Madison Feb 9), consents by Apr 9
- Switching Technologies Open Offer(OPPORTUNITY)◆
26% stake at ₹66/share, public 36% float, no promoter pledges
- Krishna Capital Open Offer(OPPORTUNITY)◆
5.44% at ₹20 cash, control change via 42.87% SPA, opens May 22
Sector Themes(6)
- M&A Surge in Industrials/Bedding(THEME)◆
3/50 filings on Somnigroup-LEG $2.5B deal (EPS accretion, $50M synergies), Comstock campus buy/lease, Hubtown scheme (21% sub stake consol), implying consolidation for scale in manufacturing ($11.2B comb sales)
- Biotech IPO/Financings Bullish(THEME)◆
5/50 positive (Alamar +195% rev, Kailera Phase 3 23% weight loss, ImageneBio $30M PP, Palvella board add), mixed sentiment but pipeline catalysts 2027-28, vs sector avg growth
- Indian Insolvency/Regulatory Wave(THEME)◆
10/50 filings (AGS 11th CoC, Reliance 9th, Hubtown NCLT scheme, Skyline fraud FIR Rs10Cr, open offers 26-5% stakes), tight liquidity (RBI ₹5.5L Cr deficit x2 days), control changes
- Microcap Financial Distress(THEME)◆
7/18 10-K/Qs mixed/neg (ALT5 net loss x45 on crypto, Digital Ally margins -13pts, Zhanling no rev/loss +11%, Sow Good Nasdaq equity fail), but 4 grew rev +17-195% YoY
- Leadership Stability Signals(THEME)◆
Positive appointments (Conagra CEO Jun1, AdvanSix CFO Apr27, Palvella dir), vs risks (Mobile CFO resign, Minerva control change), no insider trades but mgmt conviction via retention
- Liquidity Tight in India(THEME)◆
RBI 2/50 show ₹3.9L Cr SDF absorption, ₹5.5L Cr net deficit, zero money mkt vols, vs durable surplus Mar15 ₹5.1L Cr, auction Apr17 ₹32k Cr Gsecs
Watch List(8)
- Sow Good Nasdaq Compliance👁
Plan due May 22 (ext to Oct4), $100M ATM launch, monitor delisting risk post-10-K equity fail [May 22, 2026]
Shareholder/regulatory approvals, close YE2026 (outside Jan13/2027, ext Apr13/2028), EPS accretion/synergies [YE 2026]
- Kailera Phase 3 Trials👁
KaiNETIC topline 2028, oral Phase 3 H1 2027, IPO pricing post-S-1/A [2027-2028]
Board mtg Apr17 for FY26 results/dividend recommendation, analyst presentation same day [Apr 17, 2026]
- RBI GSec Auction👁
₹32k Cr re-issue (2031/2065) Apr17, settle Apr20, 'when issued' trading Apr15-17 [Apr 17, 2026]
- Minerva Gold LOI👁
Acquire Taizhou Sentian by May31 definitive, related-party control change (76% shares issued) [May 31, 2026]
- Krishna Capital Open Offer👁
Opens May22-closes Jun4, RBI/other approvals for control change [May 22-Jun 4, 2026]
- ChoiceOne AGM👁
Virtual May20, elect 5 dirs/2029 terms, comp vote, auditors ratification, 15M shares o/s [May 20, 2026]
Filing Analyses(50)
13-04-2026
RBI reported zero volumes across all money market segments (overnight and term) on April 11, 2026, indicating no activity. Today's operations resulted in net liquidity absorption of ₹3,95,370 Cr, driven by heavy SDF utilization of ₹3,91,403 Cr (1-day) and ₹4,100 Cr (2-day), with overall net liquidity from outstanding and today's operations at a deficit of ₹5,54,842 Cr. Scheduled commercial banks' cash balances with RBI stood at ₹7,54,046 Cr, below the average daily requirement of ₹7,76,432 Cr for the fortnight.
- ·Outstanding repo operations: ₹10,479 Cr at 5.34% (90 days, matures April 30, 2026) and ₹67,285 Cr at 5.26% (90 days, matures April 30, 2026)
- ·Net liquidity from outstanding operations: absorption of ₹1,59,472.26 Cr
- ·Government of India surplus cash balance as on April 10, 2026: ₹0 Cr
13-04-2026
RBI reported money market operations as on April 12, 2026, showing no transactions in overnight and term segments across call money, triparty repo, market repo, and corporate bond repo. Significant liquidity absorption occurred via Standing Deposit Facility (SDF) of ₹3,91,463 Cr at 5.00%, contributing to a net liquidity injection of -₹5,54,796.26 Cr including outstanding operations. Scheduled commercial banks held cash balances of ₹7,54,042.20 Cr with RBI against an average daily CRR requirement of ₹7,76,432 Cr for the fortnight ending April 15, 2026, amid a net durable liquidity surplus of ₹5,14,272 Cr as on March 15, 2026.
- ·No transactions (0.00) reported in overnight segment (call money, triparty repo, market repo, repo in corporate bond) or term segment (notice money, term money, triparty repo, market repo, repo in corporate bond).
- ·MSF outstanding: ₹115 Cr maturing April 13, 2026 at 5.50%; ₹0 Cr maturing April 13 from April 11.
- ·SDF outstanding: ₹46,105 Cr maturing April 13, 2026 at 5.00%; ₹4,100 Cr maturing April 13 from April 11.
- ·Repo outstanding: ₹10,479 Cr at 5.34% and ₹67,285 Cr at 5.26% maturing April 30, 2026.
- ·Government of India surplus cash balance: ₹0 Cr as on April 10, 2026.
13-04-2026
The Reserve Bank of India (RBI) launched the 73rd round of its Order Books, Inventories and Capacity Utilisation Survey (OBICUS) for the reference period January-March 2026 (Q4:2025-26). The quarterly survey, conducted since 2008, collects data from manufacturing companies on new orders, order backlogs, inventories (finished goods, work-in-progress, raw materials), production quantities/values, installed capacity, and capacity utilisation to support monetary policy formulation. Selected companies will be approached, while others can voluntarily participate via the RBI website.
- ·Survey conducted quarterly since 2008.
- ·Questionnaire available under 'Forms' > 'Survey' on RBI website.
- ·Contact: Division of Enterprise Surveys, Department of Statistics and Information Management, RBI, C-8, 2nd floor, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051; Phone: 022-26578279.
13-04-2026
The Committee of Independent Directors (IDC) of Switching Technologies Gunther Limited has issued recommendations on the Open Offer by acquirers BBU Enterprises Private Limited, Touristas Horizons Private Limited, and Mr. Nikhil Pujari to acquire up to 6,37,000 equity shares, representing 26% of the emerging share capital, at an offer price of ₹66 per fully paid-up equity share. Public shareholding is 36.35% (91,04,356 shares), while promoters and promoter group hold 63.65% (1,59,44,022 shares) with no pledged or encumbered shares. No persons acting in concert with the acquirers, and the Manager to the Offer is D & A Financial Services (P) Ltd.
- ·IDC members do not hold any equity shares in the Target Company.
- ·No pledged or encumbered promoter shares (0%).
- ·Filing Date: April 13, 2026; IDC Recommendations Date: April 11, 2026.
- ·Open Offer under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
13-04-2026
Omnipotent Industries Limited submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter and year ended March 31, 2026, confirming the regulation is not applicable as all shares are held in demat form with no requests for rematerialization or dematerialization received. The certificate was issued by Registrar and Share Transfer Agent Bigshare Services Pvt. Ltd. This routine compliance filing indicates no share transfer issues post-listing.
- ·Scrip Code: 543400
- ·ISIN: INE0JFE01012
- ·CIN: L74999MH2016PLC285902
- ·Certificate reference: BSS/74(5), dated 08/04/2026
- ·Filing date: April 13, 2026
13-04-2026
ChoiceOne Financial Services, Inc. issued a definitive proxy statement for its virtual Annual Meeting of Shareholders on May 20, 2026, at 8:00 a.m. ET, with a record date of March 31, 2026. Shareholders will vote on electing five director nominees (Keith D. Brophy, Michael J. Burke, Jr., Bruce John Essex, Jr., Steven T. Krause, Michelle M. Wendling) for terms expiring in 2029, advisory approval of executive compensation, and ratification of Plante & Moran, PLLC as independent auditors for the year ending December 31, 2026. As of March 31, 2026, 14,956,917 shares of common stock were issued and outstanding.
- ·Annual Meeting held exclusively via live webcast at www.virtualshareholdermeeting.com/COFS2026; access requires 16-digit control number from proxy.
- ·Proxy materials and Annual Report for year ended December 31, 2025 available at www.choiceone.bank/About/Investor-Relations/Proxy-Materials.
- ·Board consists of 15 directors divided into three classes; nominees for class with terms expiring in 2029.
- ·Voting requirements: plurality for directors, majority for advisory exec comp and auditor ratification.
13-04-2026
Willow Lane Acquisition Corp. filed a Form 425 disclosing social media posts on LinkedIn and X promoting its proposed business combination with Boost Run Holdings, LLC, pursuant to a Business Combination Agreement entered on September 15, 2025. The filing references a Registration Statement on Form S-4 containing a proxy statement/prospectus and urges shareholders to review SEC documents for details on the transaction involving Pubco (Boost Run Inc.) and merger subs. While highlighting potential benefits, it includes extensive forward-looking statements tempered by significant risks such as transaction failure, operational disruptions, and market uncertainties.
- ·Business Combination Agreement dated September 15, 2025
- ·Social media posts published April 10, 2026
- ·Filing date: April 13, 2026
13-04-2026
Alamar Biosciences is filing an S-1/A for an IPO offering 9,375,000 shares at a midpoint price of $16.00 per share, expecting net proceeds of approximately $133.2 million (or $154.1 million if underwriters' option for 1,406,250 additional shares is exercised in full), with total shares outstanding post-IPO at 64,890,799 (or 66,297,049). For the year ended December 31, 2025, total revenue grew 195% YoY to $74.2 million from $25.1 million in 2024, driven by product revenue surging 257% to $58.4 million, while gross profit expanded to $41.7 million; however, the company reported a net loss of $29.8 million (improved from $47.1 million in 2024), with operating expenses rising due to SG&A increasing 88% to $35.6 million amid ongoing R&D investments.
- ·1-for-2.418 reverse stock split effected on April 10, 2026.
- ·Proposed Nasdaq trading symbol: ALMR.
- ·Stock-based compensation expense increased to $2.9 million in 2025 from $0.9 million in 2024.
- ·Pro forma net loss per share for 2025: $(0.54) (unaudited).
- ·Weighted-average exercise prices: 2018 Plan options $3.18 (pre-2026) and $8.26 (post); warrants $3.55; phantom options $4.32 (pre) and $9.00 (post).
13-04-2026
On April 9, 2026, Mark Keeley resigned as Chief Financial Officer Consultant of Mobile Global Esports, Inc. Brett Rosin, the Company's Chief Executive Officer, will serve as the principal accounting officer on an interim basis until a new Chief Financial Officer is hired. The filing discloses no details on the reasons for the resignation or any compensatory arrangements.
- ·Company trades as MGAM on OTC Pink Sheets
- ·Emerging growth company status confirmed
- ·Principal executive offices: 500 Post Road East, 2nd Floor, Westport, CT 06883
13-04-2026
Minerva Gold Inc. entered a Letter of Intent on April 10, 2026, to acquire Taizhou Sentian Sanitary Ware Co., Ltd., a sanitary ware manufacturer owned by its new Sole Officer and Director Zhang Chengcheng, via issuance of common and preferred stock, with definitive agreement expected by May 31, 2026. Concurrently, Zhang Chengcheng acquired 5,000,000 shares (76.10% of 6,570,000 outstanding shares) for $264,600 cash, triggering a change in control, with prior officers Aftandil Aibekov and Meltem Alieva resigning and Zhang appointed as sole director and officer. This related-party transaction represents a strategic pivot from gold to bathroom fixtures manufacturing amid potential conflicts of interest.
- ·Taizhou Sentian founded in 2008, based in Taizhou, Zhejiang Province, China, with website cnsentian.com.
- ·Zhang Chengcheng, 36, CEO of Taizhou Sentian since 2023; prior roles include Quality Control Inspector at Cougar Shoes (2014-2016) and Head of Brand Development at Dongguan Hanghua Footwear / Jia Kuang Trading (2016-2023); Bachelor's in Electrical Engineering from University of Duisburg-Essen.
13-04-2026
Sow Good Inc. entered into a Sales Agreement with Craft Capital Management, LLC, to offer and sell up to $100 million of its common stock through an at-the-market offering on Nasdaq. However, on April 7, 2026, the company received a Nasdaq notice stating it no longer complies with the $2.5 million minimum stockholders' equity requirement per Listing Rule 5550(b)(1), based on its Form 10-K for the year ended December 31, 2025. The company has until May 22, 2026, to submit a compliance plan, with a potential extension to October 4, 2026, but faces delisting risk if unresolved.
- ·Sales conducted as 'at the market offering' under Rule 415(a)(4), including direct sales on Nasdaq.
- ·Sales Agreement pursuant to Form S-3 (File No. 333-294799, effective April 9, 2025) and Prospectus Supplement dated April 13, 2026.
- ·Company not obligated to sell any shares; either party may suspend or terminate upon notice.
- ·Nasdaq compliance plan submission deadline: May 22, 2026; potential extension to October 4, 2026.
13-04-2026
Palo Alto Networks, Inc. (PANW) entered into Amendment No. 5 to its lease with SANTA CLARA PHASE III EFH, LLC for approximately 290,082 rentable square feet at Building E, 3000 Tannery Way, Santa Clara, CA, extending the lease term 144 months from August 1, 2028, to July 31, 2040, with options for two additional 72-month extensions to 2052. Base Monthly Rent begins at $1,087,807.50 ($13,053,690 annually) for the first Extension Term year, escalating annually up to $1,352,551.91 ($16,230,622.92 annually) in the final year, with full abatement of Base Monthly Rent for the first 12 months but other charges still due. The amendment includes a Work Letter for Tenant Improvements and confirms no defaults under the existing lease.
- ·Lease originally dated May 28, 2015; prior amendments on September 16, 2016; November 16, 2016; June 22, 2017; September 29, 2017.
- ·Options to extend: First Extension Period August 1, 2040 – July 31, 2046; Second Extension Period August 1, 2046 – July 31, 2052 (no Third Extension Period).
- ·Landlord notice address: c/o CBRE Investment Management, LLC, 200 Park Avenue, 20th Floor, New York, NY 10166.
- ·Tenant accepts premises 'as-is' subject to Tenant Improvements and Tenant Improvement Allowance per Work Letter.
- ·Mutual estoppels confirm no defaults, no offsets, no security deposit held as of April 8, 2026.
- ·Brokers: CBRE, Inc. (Landlord), Newmark (Tenant); commissions payable by Landlord.
13-04-2026
Angel Studios, Inc. (NYSE: ANGX) priced an underwritten public offering of 14,300,000 shares of Class A common stock at $2.10 per share, expecting gross proceeds of approximately $30 million before underwriting discounts and expenses. The underwriters received a 30-day option to purchase up to an additional 2,145,000 shares, with closing expected on April 13, 2026, subject to customary conditions. Proceeds will fund general corporate purposes, including capital expenditures and working capital.
- ·Roth Capital Partners acting as sole book-running manager; Maxim Group LLC and Texas Capital Securities as co-lead managers; Lake Street Capital Markets as financial advisor.
- ·Shelf registration statement on Form S-3 (File No. 333-291514) declared effective by SEC on December 4, 2025.
- ·Angel has achieved the highest audience satisfaction scores in the industry and the highest average domestic box office per title among all independent studios.
13-04-2026
Ameriguard Security Services Inc. (AGSS) disclosed that its subsidiary TransportUS Inc. (TUS) lost the Veterans Affairs Long Beach CA contract after 7.5 years, resulting in a 58% loss of projected 2026 revenue or approximately $9 million annually. The contract, valued at $20,928,228 over 3.5 years, was awarded to another California corporation, with transition occurring in April 2026. However, TUS retains two southern California contracts worth $3.8 million annually and plans to protest the award while bidding on others.
- ·Contract managed by TUS for 7.5 years
- ·Transition to new contractor during April 2026
- ·TUS plans to protest the award based on post-award information
- ·TUS continues to bid on other transportation contracts of equal value
13-04-2026
Comstock Holding Companies, Inc. (CHCI) announced the acquisition of the 6.77-acre Woodland Pointe office campus in Herndon, Virginia, and executed a full-campus lease with Peraton covering the existing 185,000-square-foot Class A office tower and a new 100,000-square-foot build-to-suit office building, totaling nearly 300,000 square feet upon completion. The deal positions Peraton to fully occupy the campus in the Dulles Technology Corridor to support its technology and national security operations. This transaction advances Comstock's Institutional Venture Platform with institutional co-investors.
- ·Woodland Pointe located at 2200 Woodland Pointe Avenue, Herndon, Virginia, south of Dulles Toll Road.
- ·Existing building is LEED Gold certified with 165-person conference facility, parking garage, and green spaces.
- ·Formerly North American headquarters of Volkswagen.
- ·Comstock founded in 1985; operates via CHCI Commercial Management and CHCI Asset Management subsidiaries.
13-04-2026
ALT5 Sigma Corp reported FY2025 revenue of $24,840, more than doubling YoY from $11,887 (+109%), driven entirely by the Fintech segment. However, gross margin declined to 41% from 48% amid surging SG&A expenses to $33,039 (up 163%), leading to an operating loss of $(22,851) versus $(6,923) prior year, while a massive $402,054 unrealized loss on cryptocurrency assets drove net loss to $(344,507) from $(7,568). Adjusted EBITDA deteriorated to $(15,429) from $(1,509), with Biotech operations discontinued.
- ·Fintech segment SG&A expense $16,370 in FY2025 vs $5,456 in FY2024.
- ·Corporate and other operating expenses $16,669 in FY2025.
- ·Income tax benefit $86,742 in FY2025 from continuing operations.
- ·Net loss from discontinued Biotech operations $(3,021) in FY2025 vs income $733 in FY2024.
- ·Depreciation and amortization $5,268 in FY2025 vs $3,401 in FY2024.
13-04-2026
Digital Ally, Inc. reported total net revenues of $13,754,155 for the year ended December 31, 2025, up 1.7% YoY from $13,519,152, driven by Entertainment segment growth to $8,653,398 (up from $7,763,761) and service revenues up 16.0% to $9,416,879; however, Video Solutions revenues declined to $5,100,757 from $5,755,391, product revenues fell 19.7% to $4,337,276, and gross profit margin compressed sharply to 10% from 23%. Operating loss narrowed to -79% of revenue from -84%, and net loss per share improved to $(17.23) from $(33,488.74), though net loss attributable to common stockholders was -49% vs. -147%.
- ·Video Solutions product revenues declined 40.7% YoY primarily due to competitive pressure, new competitor products, price competition, adverse market conditions from company's financial condition, and inventory constraints limiting backlog fulfillment.
- ·Entertainment product revenues declined 7.4% YoY due to reduced scope of primary ticket sales by TicketSmarter as management focused on higher-margin events.
- ·Sales to domestic customers (law enforcement/commercial) direct via sales force; international via distributors; repair parts/services handled internally.
- ·Entertainment segment product revenues from ticket sales (e.g., Country Stampede) and service fees via TicketSmarter.com.
13-04-2026
OriginClear, Inc. reported revenue growth of 55% YoY to $6,816,843 for FY 2025, with gross profit up 8% to $1,621,076 and operating loss narrowed to $3.3M from $6.2M, while total liabilities decreased 49% to $26,711,626 and shareholders' deficit improved to ($28.4M) from ($54.9M). However, cost of revenue surged 79% to $5,195,767, net loss from continuing operations was $14.0M (improved from $18.0M but still substantial), and common shares outstanding ballooned to 15.6 billion from 1.7 billion due to conversions and issuances. Discontinued operations showed a net income of $463,530 versus a prior loss.
- ·Registered trademarks in 2025: WATERPRENEUR (Serial 90471071), The Blue Gold (Intl. TM Class 041, Serial 97734240), WATER ON DEMAND (Serial 98099605).
- ·Derivative liabilities $12,127,995 as of Dec 31 2025 (down from $14,651,326).
- ·Net income from discontinued operations $463,530 in FY 2025 vs loss of $929,987 in FY 2024.
13-04-2026
EACO Corp reported strong Q2 FY2026 results with revenues of $117,836, up 17.7% YoY from $100,132, gross profit rising 22.8% to $36,227 (margin 30.7% vs 29.5%), and net income increasing to $9,797 from $6,763. For the six months ended February 28, 2026, revenues grew 17.9% to $228,789 and net income surged 40.0% to $19,117. The balance sheet improved with total assets at $239,057 (up 3.8%), cash at $5,140 (vs $728), and current liabilities down to $54,291 from $65,919; however, inventory rose to $91,327 from $83,980 and marketable securities fell to $24,929 from $30,375.
- ·Basic EPS $2.01 for three months ended Feb 28, 2026 (vs $1.39 YoY)
- ·Diluted EPS $3.90 for six months ended Feb 28, 2026 (vs $2.79 YoY)
- ·Operating cash flow $890 for six months 2026 (vs $(1,063) in 2025)
- ·Weighted average remaining lease term 3.2 years at Feb 28, 2026 (vs 2.8 years prior)
13-04-2026
Kailera Therapeutics, Inc., an advanced clinical-stage biotechnology company, filed an S-1/A registration statement on April 13, 2026, for its initial public offering, highlighting its diversified GLP-1-based pipeline for obesity treatment led by ribupatide, a once-weekly injectable GLP-1/GIP dual agonist in global Phase 3 KaiNETIC trials (doses up to 10 mg) with demonstrated weight loss of up to 23.6% at 12 weeks (8 mg dose) and 19.2% at 48 weeks (6 mg dose). The company is also advancing oral ribupatide (up to 12.1% weight loss at 26 weeks), KAI-7535 oral small molecule, and KAI-4729 tri-agonist, while qualifying as a smaller reporting company with annual revenue under $100 million and no off-balance sheet arrangements. Topline results from Phase 3 trials are expected in 2028, with no head-to-head trials against competitors and all candidates still in development.
- ·KaiNETIC-1 initiated December 2025; KaiNETIC-3 December 2025; KaiNETIC-2 January 2026; Phase 2b high-dose March 2026.
- ·Global Phase 3 trials evaluate ribupatide doses of 4 mg, 6 mg, 8 mg, 10 mg over 76 weeks; Phase 2b up to 20 mg over 48 weeks.
- ·Plans to initiate global Phase 3 for oral ribupatide as early as first half of 2027.
- ·Exclusive worldwide rights to product candidates outside Greater China.
- ·No off-balance sheet arrangements.
13-04-2026
Zhanling International Ltd reported a net loss of $7,687 for the three months ended February 28, 2026, slightly up 1% from $7,595 in 2025, and $26,866 for the nine months, up 11% from $24,161, driven solely by general and administrative expenses with no revenue. However, total assets grew significantly to $5,506 from $166 as of May 31, 2025, current liabilities decreased to $3,124 from $9,122, and stockholders' deficit improved to $(41,419) from $(48,231), supported by a massive dilution in shares outstanding to 3,441,000 from 73,200. Cash balances remained at $0, with all operating cash used of $38,204 offset exactly by financing advances from related and non-related parties.
- ·Basic and diluted EPS for nine months ended Feb 28, 2026: (0.01) vs (0.33) in 2025.
- ·Prepayments increased to $5,506 from $166.
- ·Due to related parties: $38,696 as of Feb 28, 2026 vs $38,285 as of May 31, 2025.
- ·No cash balances at beginning or end of periods; no interest or taxes paid.
- ·Common stock authorized: 500,000,000 shares, $0.001 par value.
13-04-2026
AdvanSix Inc. (NYSE: ASIX) announced the appointment of Patrick C. Day as Senior Vice President and Chief Financial Officer, effective April 27, 2026, reporting to President and CEO Erin Kane. Day, previously VP of Financial Planning and Analysis and Investor Relations at FMC Corporation, replaces interim CFO Christopher Gramm, who will continue as Vice President of Corporate Finance and Strategic Financial Planning & Analysis. The appointment is positioned as strengthening leadership for growth and value creation.
- ·Filing Date: April 13, 2026
- ·Appointment effective: April 27, 2026
- ·Day's education: Bachelor’s degree in finance from Elizabethtown College; Master’s degree in accounting and tax from the University of Connecticut
13-04-2026
Pershing Square Holdco, L.P. filed an S-1/A registration statement on April 13, 2026, for the PSUS IPO and PSUS Private Placement, which are expected to materially expand permanent capital AUM with PSUS as the flagship NYSE-listed vehicle pursuing the core investment strategy. The firm generates revenues from predictable management fees, including a quarterly HHH Base Management Fee of $3,750,000 and a 0.375% HHH Variable Management Fee, alongside performance fees with a Preferred Performance Fee allocation. HHH is advancing its diversified holding company strategy through the $2.1 billion Vantage Acquisition, agreed on December 17, 2025, and expected to close in Q2 2026, while past examples include raising $1.1 billion via PSVII in September 2021 for Universal Music Group; however, the strategy involves risks from concentrated portfolios and potential portfolio company resistance.
- ·Founded in 2003.
- ·HHH Transaction completed May 5, 2025.
- ·PSUS subject to 1940 Act restrictions including investment, leverage, derivative, and diversification requirements.
- ·In February 2024, expanded fee offset arrangement for PSH to reduce performance fees and increase demand for PSH shares.
- ·Investment in Chipotle initiated in 2016, leading to board changes and turnaround initiatives.
13-04-2026
Jagsonpal Pharmaceuticals Limited allotted 1,76,900 equity shares of Rs. 2/- each under the JPL ESOP 2022 to eligible employees upon exercise of vested options on April 13, 2026. This increased the paid-up share capital from Rs. 13,39,24,500 (6,69,62,250 shares) to Rs. 13,42,78,300 (6,71,39,150 shares), representing a minor dilution of approximately 0.26%. The new shares rank pari-passu with existing equity shares.
- ·Distinctive numbers of allotted shares: 6,69,62,251 to 6,71,39,150
- ·ISIN Number: INE048B01035
- ·Prior filing dates for Regulation 10(b): July 26, 2022 (BSE), July 27, 2022 (NSE)
- ·Par value per share: Rs. 2/-
13-04-2026
Somnigroup International Inc. (NYSE: SGI) announced a definitive agreement to acquire Leggett & Platt, Incorporated (NYSE: LEG) in an all-stock transaction valued at approximately $2.5 billion, with LEG shareholders receiving 0.1455 SGI shares per LEG share and owning about 9% of the combined company on a fully diluted basis. The transaction, approved by both boards and expected to close by year-end 2026 subject to shareholder and regulatory approvals, will result in a combined company with approximately $11.2 billion in 2025 net sales, $1.7 billion adjusted EBITDA, and $1.1 billion operating cash flow, operating 175 manufacturing facilities across 36 countries with over 36,000 employees. Strategic benefits include continued vertical integration, expanded markets, reduced leverage, and immediate adjusted EPS accretion before synergies.
- ·Exchange ratio: 0.1455 shares of Somnigroup common stock per share of Leggett & Platt common stock
- ·Transaction does not require Somnigroup shareholder approval
- ·Leggett & Platt expected to operate as a separate business unit post-close, maintaining offices in Carthage, Missouri
- ·Karl Glassman to lead Leggett & Platt post-closing and assist with transition to new CEO within 12 months
- ·Nearly 50 years of collaboration between Somnigroup and Leggett & Platt
13-04-2026
Clear Channel Outdoor Holdings, Inc. announced the successful results of its consent solicitation, obtaining the requisite consents as of April 9, 2026, for amendments to indentures governing its Senior Secured Notes totaling $865 million (7.875% due 2030), $1.15 billion (7.125% due 2031), and $900 million (7.500% due 2033). Supplemental indentures were executed and delivered, making the amendments effective immediately prior to the consummation of the pending merger with Madison Merger Sub Inc., pursuant to the Merger Agreement dated February 9, 2026. If the merger does not close, the amendments will automatically cease to be effective.
- ·Requisite consents provided and not revoked as of April 9, 2026, per D.F. King & Co., Inc.
- ·Solicitation agents: J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC.
- ·Information agent contact: (646) 971-2689 (Banks/Brokers), (800) 290-6433 (others), CCO@dfking.com
13-04-2026
On April 12, 2026, ImageneBio, Inc. entered into a Securities Purchase Agreement with institutional and accredited investors for a private placement of pre-funded warrants to purchase up to 5,770,335 shares of common stock at $5.199 per Warrant Share, expecting gross proceeds of approximately $30 million upon closing on or about April 14, 2026. Net proceeds will fund late-phase development readiness in atopic dermatitis and expansion of IMG-007 into additional indications including alopecia areata. The company agreed to file a registration statement for resale of Warrant Shares within three business days following August 1, 2026.
- ·Pre-funded warrants have exercise price of $0.001 per Warrant Share, exercisable immediately on cashless basis until fully exercised.
- ·Closing subject to customary conditions; securities issued under Section 4(a)(2) exemption with restrictive legends.
- ·Registration Rights Agreement includes cash penalties for registration failures.
13-04-2026
Aftertrade Broking Private Limited, as Manager to the Offer, submitted the Offer Opening Advertisement and Corrigendum to the Detailed Public Statement on April 13, 2026, for an open offer by five Acquirers (Mr. Arvind Karsandas Bhanushali, Mrs. Deepali Arvind Bhanushali, Mr. Jay Arvind Bhanushali, Mr. Nikunj Velji Mange, and Mr. Raj Arvind Bhanushali) and Mrs. Shraddha Nikunj Mange (PAC) to acquire 26,76,180 equity shares of Aspira Pathlab & Diagnostics Limited under SEBI Takeover Regulations. The advertisement was published in Financial Express (English All Editions), Jansatta (Hindi All Editions), and Mumbai Lakshdeep (Marathi Edition). No financial performance metrics or period comparisons are provided in the filing.
- ·Published in Financial Express (English All Editions), Jansatta (Hindi All Editions), Mumbai Lakshdeep (Marathi Edition)
- ·Submitted to BSE Limited for record
- ·SEBI Reg. No: INM000013110 for Manager to the Offer
13-04-2026
Leggett & Platt, Incorporated has entered into a Merger Agreement with Somnigroup International Inc., whereby a wholly-owned subsidiary of Somnigroup will merge with Leggett & Platt, with Leggett surviving as a subsidiary, and each share of Leggett common stock converted into 0.1455 shares of Somnigroup common stock. The transaction, unanimously approved by both boards, is expected to qualify as a tax-free reorganization and is subject to shareholder approval, regulatory clearances including HSR, NYSE listing, and no material adverse effects, with an outside date of January 13, 2027 (extendable to April 13, 2028 for regulatory delays). Termination fees include $64M payable by Leggett for superior proposals and $80M reverse fee by Somnigroup for regulatory failures.
- ·Exchange Ratio: 0.1455 shares of Parent common stock per share of Company common stock, with equitable adjustments for stock splits.
- ·Stock options, RSUs, and PSUs will be converted/assumed by Parent with terms adjusted by Exchange Ratio; PSUs with open periods deemed at maximum performance (200% of target).
- ·Company non-solicitation covenant allows superior proposal with 4-business day notice period and good faith negotiations.
- ·Outside Date: January 13, 2027, automatically extended up to April 13, 2028 if only regulatory conditions remain.
13-04-2026
Somnigroup International Inc. (NYSE: SGI) announced a definitive agreement to acquire Leggett & Platt, Incorporated (NYSE: LEG) in an all-stock transaction valued at approximately $2.5 billion, with LEG shareholders receiving 0.1455 SGI shares per LEG share, resulting in 9% ownership of the combined company. The deal is expected to drive immediate adjusted EPS accretion before synergies, $50 million annual run-rate cost synergies (with $10 million in the first 12 months), and combined 2025 pro forma net sales of $11.2 billion, adjusted EBITDA of $1.7 billion, and operating cash flow of $1.1 billion. The transaction anticipates closing by year-end 2026, subject to LEG shareholder and regulatory approvals, with no Somnigroup shareholder vote required.
- ·Leggett & Platt net leverage was 2.4 times adjusted EBITDA as of December 31, 2025.
- ·Somnigroup expects to leave LEG’s existing long-term bond debt in place post-transaction.
- ·LEG to operate as a separate business unit within Somnigroup post-close, with Karl Glassman leading initially and transitioning to new CEO within 12 months.
- ·Transaction unanimously approved by both boards; no SGI shareholder approval required.
13-04-2026
The Board of Directors of Santosh Fine-Fab Ltd. approved the resignation of Ms. Niti Jain as Company Secretary & Compliance Officer, effective March 18, 2026, and placed on record its appreciation for her contributions. The Board also approved the appointment of Ms. Radha S. Sharma (also referred to as Radha Sushit Kumar Sharma) as Company Secretary & Compliance Officer, effective April 13, 2026, pursuant to Sections 203 and 205 of the Companies Act, 2013. The meeting was held on April 13, 2026, from 4:30 PM to 5:00 PM at the company's registered office.
- ·Resignation accepted with effect from 18 March 2026.
- ·Appointment authorized under Companies Act, 2013, with Mr. Santosh R. Tulsiyan authorized to handle filings with Registrar of Companies, Mumbai.
- ·Meeting location: 113/113, Sanjay Building No.6, Mittal Estate, Andheri (East), Mumbai - 400059.
- ·CIN: L17112MH1981PLC025443.
13-04-2026
Conagra Brands, Inc. (NYSE: CAG) announced the appointment of John Brase as President and Chief Executive Officer effective June 1, 2026, succeeding Sean Connolly who will step down from his leadership roles and the Board on May 31, 2026. Brase, with over 35 years of experience including roles at The J.M. Smucker Co. and Procter & Gamble where he led a $6B business, will also join the Board. The transition is described as smooth, with praise for Connolly's decade-long leadership in transforming Conagra into a pure-play food company generating fiscal 2025 net sales of nearly $12B.
- ·Brase previously oversaw U.S. retail, international, and Away from Home businesses at Smucker
- ·Conagra headquartered in Chicago
- ·Media contact: Mike Cummins (312-549-5257)
- ·Investor contact: Matthew Neisius (402-240-3226)
13-04-2026
Palvella Therapeutics, Inc. increased its Board of Directors from six to seven members and appointed John Doux, M.D., as a Class III director effective April 13, 2026, with term expiring at the 2026 Annual Meeting of Stockholders. Dr. Doux, a board-certified dermatologist with extensive experience in healthcare investments and prior service on the Company's board pre-reverse merger, was granted an option to purchase 6,000 shares of common stock vesting over 36 months per the Director Compensation Policy. The Board determined Dr. Doux to be independent under Nasdaq rules, with no related party transactions or family relationships.
- ·Dr. Doux, age 57, previously served on the Company's board from 2019 to 2022 prior to its reverse merger.
- ·No arrangements or understandings pursuant to which Dr. Doux was selected as director.
- ·Dr. Doux served on boards of multiple biotechnology companies, including Ceptaris Therapeutics acquired by Actelion.
13-04-2026
AGS Transact Technologies Limited, under Corporate Insolvency Resolution Process (CIRP), held its 11th Committee of Creditors meeting on April 10, 2026, at 12:00 noon via video conferencing. The disclosure was filed with BSE (Scrip Code: 543451) and NSE (Symbol: AGSTRA) on April 13, 2026, pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015. No outcomes or decisions from the meeting were detailed in the filing.
- ·IBBI Registration No: IBBI/IPA-002/IP-N00109/2017-2018/10257
- ·AFA Details: AA2/10257/02/311226/204257, Valid till 31.12.2026
- ·Process Email ID: agscirp@gmail.com
13-04-2026
Santosh Fine-Fab Ltd. appointed Ms. Radha Sushil Kumar Sharma as Company Secretary and Compliance Officer effective April 13, 2026, following approval at a Board Meeting held on the same day at 4:30 PM at the company's registered office. The appointment complies with Section 203 and 205 of the Companies Act, 2013, and Regulation 6(1) of SEBI (LODR) Regulations, 2015. An intimation was sent to BSE Limited, with a certified board resolution and signed letter of appointment enclosed.
- ·Board Meeting location: 113/113, Sanjay Building No.6, Mittal Estate, Andheri (E), Mumbai 400059
- ·Ms. Radha Sushil Kumar Sharma's ICSI Membership No. A46047 / ACS No. 46047, admitted on June 27, 2016
- ·Managing Director authorized to file necessary forms with Registrar of Companies, Mumbai
13-04-2026
Kedia Construction Co. Ltd. has received and disclosed the certified copy of the NCLT Mumbai Bench order approving the Scheme of Arrangement and Amalgamation between Kirti Investments Limited and Kedia Construction Company Limited, pursuant to Regulation 30 of SEBI LODR Regulations, 2015. The disclosure was made to BSE Limited on April 13, 2026, referencing an earlier intimation. No financial impacts or performance metrics were detailed in the filing.
- ·CIN No.: 145200MH1981P1C025083
- ·NCLT: Mumbai Bench
- ·Security Code: 508993
- ·Director DIN: 00377686
13-04-2026
13-04-2026
The Reserve Bank of India announced an auction for the re-issue of two Government of India dated securities totaling a notified amount of ₹32,000 crore: ₹21,000 crore for 6.36% GS 2031 (repayment Feb 16, 2031) and ₹11,000 crore for 6.90% GS 2065 (repayment Apr 15, 2065). The Government of India has the option to retain additional subscription up to ₹2,000 crore for each security. The auction is scheduled for April 17, 2026, with settlement on April 20, 2026, conducted via the e-Kuber system using multiple price method.
- ·Auction conducted using multiple price method; non-competitive bids 10:30-11:00 a.m., competitive 10:30-11:30 a.m. on April 17, 2026.
- ·Eligible for 'When Issued' trading from April 15 to April 17, 2026.
- ·Non-competitive segment up to 5% of notified amount allotted at weighted average yield/price of competitive bids.
13-04-2026
Santosh Fine-Fab Ltd. appointed Ms. Radha Shushil Kumar Sharma as Company Secretary and Compliance Officer effective April 13, 2026, pursuant to Section 203 of the Companies Act, 2013 and Regulation 6(1) of SEBI LODR Regulations, 2015. This follows the resignation of the previous Company Secretary, Ms. Niti Jain, on March 18, 2026. Ms. Sharma is an Associate Member of the Institute of Company Secretaries of India (Membership No. A46047) with a B.Com degree and experience in corporate and allied laws.
- ·Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 and SEBI Circular CIR/CFD/CMD/4/2015 dated September 09, 2015
- ·Security Code: 530035
- ·CIN: L17112MH1991PLC025443
13-04-2026
NCL Industries Limited's Board reviewed a fine of Rs. 54280/- (inclusive of GST) levied by NSE on February 13, 2026, for delayed filing of the shareholding pattern for the quarter ended December 31, 2025. The waiver application was rejected, highlighting a compliance lapse. The Board emphasized strict adherence to SEBI (LODR) Regulations and advised management to stay updated on all amendments and regulatory changes.
- ·Fine notice reference: NSE/LIST-SOP/FINES/0155 dated February 13, 2026
- ·Company intimation dated February 16, 2026
- ·Board meeting held on April 13, 2026
13-04-2026
Reliance Home Finance Limited, under Corporate Insolvency Resolution Process (CIRP) initiated on September 20, 2025, held its 9th Committee of Creditors (CoC) meeting on April 15, 2026, at 06:00 P.M. IST via video conferencing, as intimated by Resolution Professional Umesh B. Sonkar. The filing to BSE and NSE fulfills disclosure requirements under SEBI LODR Regulations. No outcomes or decisions from the meeting were disclosed.
- ·BSE Scrip Code: 540709
- ·NSE Symbol: RHFL
- ·ISIN: INE217K01011
- ·RP Registration: IBBI/IPA-001/IP-P-02619/2021-2022/14043 (Valid upto December 31, 2026)
- ·Email for Correspondence: cirp.rhfl@yahoo.com
13-04-2026
The NCLT Mumbai Bench issued an order on April 9, 2026, directing Hubtown Limited (Transferee Company) to convene meetings of its equity shareholders and unsecured creditors to consider and approve the proposed Scheme of Arrangement involving the merger of Saicharan Consultancy Private Limited (Transferor Company) into Hubtown, with an Appointed Date of April 1, 2025. The scheme aims to consolidate Hubtown's stake in subsidiary Rare Townships Private Limited (RTPL) by absorbing Saicharan's 21.17% holding in RTPL, where Hubtown already holds 66.93%, enhancing ownership and operational efficiencies. Share exchange ratio is 648 Hubtown equity shares (INR 10 each) for every 1 Saicharan equity share (INR 10 each).
- ·Board approvals for the Scheme: Saicharan on February 14, 2026; Hubtown on February 14, 2025 (Audit Committee and Independent Directors).
- ·No secured creditors in Saicharan Consultancy as of September 30, 2025.
- ·No preference shareholders, inquiries, investigations, winding-up petitions, or IBC proceedings against either company.
- ·'No adverse observation' letters from BSE (November 7, 2025) and NSE (November 11, 2025).
13-04-2026
Ashu Bishnoi (Acquirer 1) and Yagnik Tank (Acquirer 2) are launching an open offer to acquire up to 18,04,508 fully paid-up equity shares of face value ₹10 each, representing 5.44% of the emerging voting share capital of Krishna Capital and Securities Limited (KRISHNACAP), at ₹20 per share payable in cash. This offer is triggered by a Share Purchase Agreement dated March 26, 2026, to acquire 13,53,892 sale shares (42.87% of pre-issue share capital) from selling promoters for ₹2,70,77,840, resulting in a change in control and management. While offering public shareholders an exit at ₹20 per share, the transaction involves risks such as potential statutory approvals (including RBI) and impacts from ownership change.
- ·Filing date: April 13, 2026; Public Announcement: March 26, 2026.
- ·Offer opens: May 22, 2026; Offer closes: June 04, 2026; Identified Date: May 08, 2026.
- ·Offer not conditional on minimum acceptance; subject to potential RBI approval and other statutory approvals.
- ·Manager: Grow House Wealth Management Private Limited (SEBI Reg. INM000013262); Registrar: Skyline Financial Services Private Limited (SEBI Reg. INR000003241).
13-04-2026
Skyline Ventures India Limited filed an FIR (No. 542/2026) on April 9, 2026, alleging fraud by former directors Mr. Prashanth Mitta and Ms. Asha Mitta, along with associates, involving suspicious unsecured loan of Rs. 1.78 Crores from Raj Breeders and Hatcheries Private Limited, purportedly for a Rs. 2.00 Crores work order from Verrkotech Solutions Private Limited that may lack legitimacy. Funds were allegedly diverted to personal accounts, leading to potential falsification of books, unauthorized bank operations, and significant financial stress culminating in an IBC Section 7 insolvency petition filed on November 10, 2025, by the lender. Estimated fraud impact is Rs. 10.45 Crores (market cap basis), with unreturned company assets worth INR 8 lakhs.
- ·FIR filed at Madhapur Police Station, Cyberabad on April 9, 2026
- ·Transactions occurred between October and November 2025
- ·AGM on September 30, 2025 rejected financial statements and re-appointment of Prashanth Mitta
- ·Shareholder requisition notice on October 16, 2025; EGM held on December 31, 2025 removing directors
- ·Board meeting on October 3, 2025 approving Prashanth Mitta as signatory (validity questioned)
- ·GST registrations inactive for Skyline Ventures and Verrkotech at relevant time
13-04-2026
Jio Financial Services Limited announced a Board of Directors meeting scheduled for April 17, 2026, to consider and approve standalone and consolidated audited financial results for the quarter and year ended March 31, 2026. The board will also recommend a dividend on equity shares for the financial year ended March 31, 2026. An analyst presentation on these financial results will follow the meeting on the same day.
- ·Scrip Code: 543940
- ·Trading Symbol: JIOFIN
- ·CIN: L65990MH1999PLC120918
- ·Registered Office: 1st Floor, Building 4NA, Maker Maxity, Bandra Kurla Complex, Bandra (East), Mumbai - 400051
13-04-2026
ICICI Home Finance Company Limited filed its annual disclosure as a large corporate under SEBI circular for FY2026, reporting incremental borrowings of ₹8,426.05 Cr. Mandatory borrowings through debt securities were ₹2,106.51 Cr (25% of incremental), with actual debt securities borrowings of ₹2,155.00 Cr, exceeding the requirement with no shortfalls carried forward from FY2025 or for FY2026. No penalties were applicable for the 3-year block period FY2026-28.
- ·CIN: U65922MH1999PLC120106
- ·Disclosure covers 3-year block period FY2026, FY2027 & FY2028
- ·Shortfall from FY2025 carried forward to FY2026: none
- ·Quantum of prior shortfall met: none
- ·Penalty/fine for the block: Nil
13-04-2026
El Forge Limited confirmed it is not classified as a 'Large Corporate' under the SEBI framework as of March 31, 2026, making SEBI Circulars SEBI/HO/DDHS/P/CIR/2021/613 (dated August 10, 2021, updated April 13, 2022) and SEBI/HO/DDHS/DDHSRACPODI/P/CIR/2023/172 (dated October 19, 2023) non-applicable to the company. The disclosure was filed with BSE Limited on April 13, 2026, by the Company Secretary.
- ·BSE Scrip code: 531144
- ·ISIN: INE158F101017
- ·Company CIN: L34103TN1934PLC000669
13-04-2026
Innokaiz India Limited has confirmed to BSE that it does not qualify as a Large Corporate under the SEBI framework for fund raising by issuance of debt securities (Chapter XII of SEBI Operational Circular dated August 10, 2021). As a result, no Initial Disclosure (Annexure A) or Annual Disclosure (Annexure B2) is required for the Financial Year ended March 31, 2026. This compliance confirmation references multiple SEBI and BSE circulars from 2018 to 2022.
- ·Company identifiers: INNOKAIZ | 543905 | INE0LDI01022
- ·Referenced circulars: SEBI/HO/DDHS/CIR/P/2018/144 (Nov 26, 2018), SEBI/HO/DDHS/P/CIR/2021/613 (Aug 10, 2021, updated Apr 13, 2022), BSE LIST/COMP/05/2019-20 (Apr 11, 2019), BSE LIST/COMP/59/2019-20 (Mar 3, 2020), BSE Notice 20220427-2 (Apr 27, 2022)
- ·Disclosure timelines: Initial within 30 days from FY start; Annual within 45 days of FY end
13-04-2026
Amba Enterprises Ltd. disclosed to BSE Ltd. that it does not qualify as a 'Large Corporate' for the year ended March 31, 2026, under SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, regarding fundraising by issuance of debt securities by large corporates. The company enclosed Annexure-B2 as required by the circular.
- ·Scrip Code: 539196
- ·Disclosure date: April 13, 2026
13-04-2026
Arvind SmartSpaces Limited confirmed it does not qualify as a 'Large Corporate' under SEBI Circular No. SEBI/HO/DDHS/DDHS-RACPOD1/P/CIR/2023/172 dated 19th October 2023 for FY 2026-27. Outstanding borrowings as on 31st March 2026 stood at ₹458.70 Crores. The highest credit rating during the previous FY was IND A+/Stable by Indian Ratings and Research (IRA).
- ·CIN: L45201GJ2008PLC055771
- ·Security Code: 539301, Symbol: ARVSMART, Security ID: ARVSMART
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
🇺🇸 More from United States
View all →April 06, 2026
US Pre-Market SEC Filings Roundup — April 06, 2026
US Pre-Market SEC Filings Roundup
April 06, 2026
US Merger & Acquisition SEC Filings — April 06, 2026
US Merger & Acquisition SEC Filings
April 06, 2026
US IPO Pipeline SEC S-1 Filings — April 06, 2026
US IPO Pipeline SEC S-1 Filings
April 06, 2026
US Corporate Board Director Changes SEC Filings — April 06, 2026
US Corporate Board Director Changes SEC Filings